The Harrington Discovery Institute at University Hospitals in Cleveland named Jonathan S. Stamler, MD, president, according to a Cleveland Jewish News report. 1. Dr. Stamler currently serves as ...
Drug discovery institutes comprised of experienced drug discovery scientists collaborating with fundamental biomedical researchers provide solutions to many of the challenges in translating biomedical ...
Enhanced Genomics’ 3D multi-omics platform harnessed to rapidly identify multiple novel therapeutic targets that were undetectable using conventional genomic approaches Breakthrough demonstrates the ...
Rochester, NY – March 10, 2025 – Empire Discovery Institute (EDI), a leading non-profit drug discovery and development accelerator, is pleased to announce the appointment of Dr. Ronald Newbold as ...
CLEVELAND, Ohio – Promising results from a pivotal Phase 3 clinical trial of an investigational heart-attack drug were announced this week as part of the late-breaking sessions at the American Heart ...
Enhanced Genomics ('Enhanced'), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results